Skip to content
Output Biosciences logo

Output Biosciences

Hiring

Output Biosciences is a YC Summer 2021 (S21) company. Based in New York, NY, USA. Team of 6.

  • AI-powered Drug Discovery
  • Generative AI
  • Biotech

About Output Biosciences

GPAgent's own fund-neutral profile, written from public information. Updated Oct 4, 2026.

Summary

Output Biosciences builds large-scale AI models designed to reason over biological systems at the molecular level, from individual molecular interactions up to whole-system behavior. Its core architecture, which the company calls Mechanistic Reasoning, decomposes biological interactions into their component parts to derive governing principles, replacing manual hypothesis-driven research. The target output is the discovery of new biology and the design of novel therapeutics, work traditionally done by experimental scientists over years of iterative lab cycles.

From the Y Combinator listing

How Output Biosciences describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Teaching Generative AI the Language of Biology

Output Biosciences is pioneering Biologically-Aware Generative AI to finally understand complex biological systems. Our new generative AI architecture can handle the extremely long, nonlinear, fragmented, and high dimensional data of biological systems. We are building Large Biological Models that can generate breakthrough medicines and transform the way we diagnose, treat and prevent disease.

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
New York, NY, USA
Team size
6
Status
Active
Stage
Early

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works